Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults
N/A
6 Years
30 Years
6 Years
30 Years
Open (Enrolling)
Both
Ewing Sarcoma, Osteosarcoma
Both
Ewing Sarcoma, Osteosarcoma
Trial Information
Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults
Inclusion Criteria:
- Ewing or Osteosarcoma, proven by biopsy and histopathology
- all patients are treated by chemotherapy defined by EURAMOS and EURO-EWING protocol
Exclusion Criteria:
- Patients under the age of 6 years old
- patients with contra-indication for MR exam (pace-maker...)
- Patients with renal insufficiency
- Claustrophobia
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
tumor necrosis - therapy response
Outcome Description:
correlation of MRI findings with clinical findings during chemotherapy correlation of diffusion weighted MRI and histopathology results after surgical resection. Calculation of apparent diffusion coefficient : is it a valuable parameter?
Outcome Time Frame:
6 months
Safety Issue:
No
Authority:
Belgium: Federal Agency for Medicinal Products and Health Products
Study ID:
FUBEO
NCT ID:
NCT01780779
Start Date:
June 2009
Completion Date:
June 2014
Related Keywords:
- Ewing Sarcoma
- Osteosarcoma
- Diffusion weighted MRI
- Patient outcome assessment
- Treatment response
- Histopathology
- Osteosarcoma
- Sarcoma, Ewing's
- Neuroectodermal Tumors, Primitive, Peripheral
- Sarcoma
Name | Location |
|---|
